Current status date:
2019-10-17
DIN:
00481408
Electronic product monograph is not available
Company:
ALCON CANADA INC
2665 Meadowpine Blvd
Mississauga
Ontario
Canada
L5N 8C7
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
American Hospital Formulary Service (AHFS):
See footnote 3
52:32.00
,
04:04.20
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
NAPHAZOLINE HYDROCHLORIDE
|
0.025 %
|
PHENIRAMINE MALEATE
|
0.3 %
|